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that SR-B1 and CD36-mediated uptake of cholesterol only becomes limiting during high-cholesterol diets (33) . To further identify proteins that could be involved in cholesterol uptake a jejunal cDNA library was screened for features expected of a cholesterol transporter and Niemann-Pick C1 Like 1 (NPC1L1) emerged as the only credible candidate. Moreover, NPC1L1 knockout mice exhibited a significant reduction of cholesterol absorption (1) . The subsequent identification of NPC1L1 as the target of the cholesterol absorption inhibitor ezetimibe (13, 15, 50) has confirmed its role in uptake of cholesterol, and today it is considered the main player in intestinal cholesterol absorption.
NPC1L1 belongs to the NPC1 family of lipid transport facilitators and shares 51% amino acid similarity with NPC1 (11) . Both are membrane proteins containing 13 putative transmembrane domains, 5 of which are similar to the sterol sensing domain (SSD) found in, for example, 3-hydroxy-3 methylglutaryl coenzyme A reductase (HMG CoA reductase), the ratecontrolling enzyme in the cholesterol synthesis (9 -11, 48) . NPC1 is a ubiquitously expressed protein involved in egress of cholesterol from the lysosomes to the endoplasmac reticulum and the plasma membrane (6) . NPC1L1 on the other hand is mainly expressed in the liver and small intestine (1) . NPC1 and NPC1L1 have similar membrane topology (48) , and the binding site for cholesterol in NPC1 has been mapped to the NH 2 -terminal luminal loop 1 (21, 26) . The binding site for cholesterol in NPC1L1 has yet to be mapped, but, because of the high degree of homology to NPC1, it is expected to reside in the luminal orientated NH 2 -terminal. Ezetimibe has been found to bind to a region between the transmembrane helix 2 and 3 at the luminal surface of the enterocyte (50) .
Although NPC1L1 has been reported to reside primarily in the apical membrane of rat (1, 23) and human enterocytes (38) , intracellular localization of NPC1L1 has been observed in a hepatoma cell line (12) . Furthermore, by use of enhanced green fluorescent protein-tagged NPC1L1, the transporter has been shown to traffic between the plasma membrane and intracellular compartments in rat hepatoma cells following cholesterol depletion by methyl-␤-cyclodextrin (36, 52) . In hepatoma cells NPC1L1 was proposed to be internalized via clathrin-coated pits, and binding of ezetimibe blocks both the endocytosis of NPC1L1 as well as the uptake of cholesterol, suggesting that cholesterol is internalized by NPC1L1 via a receptor-mediated mechanism (16) .
In the present work we studied the cholesterol dependency of the localization of NPC1L1 in the enterocyte as well as the uptake of 22-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-23, 24-bisnor-5-cholen-3␤-ol (NBD-cholesterol), a fluorescent cholesterol analog, using a mucosal explant system (8) . We found that NPC1L1 traffics from the brush border membrane to an endosomal compartment after exposure to cholesterol. In contrast, NBD-cholesterol rapidly appeared throughout the cytosol, also under conditions nonpermissible for endocytosis, indicating an uptake by a membrane transporter rather than via an endocytic receptor. We therefore propose that cholesterol is transported through the brush border membrane by NPC1L1 acting as membrane transporter. In addition we propose that NPC1L1 senses the luminal cholesterol concentration and traffics to an endosomal compartment to downregulate the absorption of cholesterol.
MATERIALS AND METHODS

Materials.
Rabbit anti-NPC1L1 and rabbit anti-NPC1 were purchased from Novus Biological (http://www.novusbio.com/), goat antiearly endosome antigen 1 (EEA1) was from Santa Cruz (http:// www.scbt.com/), rabbit anti-alkaline phosphatase was from Biogenesis (http://www.biogenesis.co.uk/); the following antibodies were previously described; mouse anti-aminopeptidase N (APN) (14) , rabbit anti-lactase (42), rabbit anti-human intestinal brush border (41) , and rabbit anti-sucrase-isomaltase (40) . Secondary Alexa 488/594 conjugated antibodies, Prolong Gold antifade reagent with 4,6-diamidino-2-phenylindole (DAPI), Image-iT FX signal enhancer and NBD-cholesterol were from Invitrogen (www.probes.invitrogen. com). Fluorescent mounting media, secondary horseradish peroxidase (HRP)-conjugated antibodies, and secondary anti-rabbit antibodies for conjugation to gold particles were purchased from DAKO (http:// www.dako.dk/). The secondary anti-rabbit antibodies were conjugated to gold particles of ϳ13 nm in diameter prepared according to Ref. 43 . Ox gall powder, pancreatin, cholesterol, and chlorpromazine were from Sigma (http://www.sigmaaldrich.com). ECL Western blot detection kit was from GE Healthcare, Little Chalfont, UK.
Organ culture of small intestinal explants. Porcine jejunum was obtained from fasted pigs by licensed staff from Department of Experimental Medicine, the Panum Institute, Copenhagen, Denmark. Mucosal explants from porcine jejunum were cultured in MEM media or MEM media enriched with 1% ox gall powder and 1% cholesterol for 0.5 or 1 h at 37°C. In some experiments the tissue was not cultured but fixed immediately after excision from the pig.
For the uptake experiments with NBD-cholesterol, the following solution was prepared: NBD-cholesterol (0.5 mg) was dissolved in 0.1 ml ethanol and mixed with 0.5 ml of corn oil. 10 mg of bile and 10 mg of pancreatin were dissolved in 4.5 ml of RPMI medium. The two solutions were mixed and incubated at 37°C overnight (ON) to generate a medium containing mixed micelles with NBD-cholesterol. Explants were cultured for 15 min at 37°C or for 1 h at 4°C. For the uptake experiments using chlorpromazine the explants were preincubated in RPMI media in the presence or absence of 10 g/ml chlorpromazine for 1 h at 37°C and then in NBD-cholesterol media formulated as above in the presence or absence of the inhibitor for 15 min at 37°C.
Immunofluorescence microscopy. Explants were fixed in 4% paraformaldehyde in 0.1 M sodium phosphate, pH 7.2 (PB) for 2 h at 4°C, briefly rinsed in PB, and stored in 1% paraformaldehyde in PB. The explants were either embedded in paraffin or snap frozen in precooled 2-methylbutane. In some experiments the explants were cryoprotected by infusion ON with 25% sucrose in PB before being snap frozen in 2-methylbutane. Paraffin-embedded tissue was cut into sections of 4 -5 m in a Leica RM 2165 rotary microtome, and frozen explants were cut into sections of 6-to 7-m thickness in a Leica CM 1850 cryostat. The sections were rinsed with 50 mM Tris, 150 mM NaCl, containing 20 mM glycine, pH 7.4 (buffer A), incubated with Image-iT FX signal enhancer for 30 min, rinsed with 50 mM Tris, 150 mM NaCl, containing 0.5% ovalbumin, 0.1% gelatin, 0.05% Tween 20, and 0.2% Teleostan gelatin, pH 7.4 (buffer B). The sections were then incubated with rabbit anti-NPC1L1, rabbit anti-NPC1, mouse anti-APN and goat anti-EEA1, in buffer B, rinsed with buffer B and incubated with secondary Alexa 594/488 conjugated antibodies in buffer B. The sections were subsequently rinsed with buffer B, with 50 mM Tris, 150 mM NaCl, pH 7.4 (buffer C), and with water before being mounted with fluorescent mounting media or antifade reagent with DAPI. The sections were finally examined in a Leica DM 4000 B microscope equipped with a Leica DC 300 FX digital camera. Control experiments were included in parallel in which the primary antibodies were omitted.
Immunoelectron microscopy. Explants were fixed in 4% paraformaldehyde for 2 h at 4°C and infused ON with PB containing 2.3 M sucrose and 1% paraformaldehyde before being snap frozen in liquid N 2. Ultrathin sections of ϳ50 nm were cut in a RMC MT 6000-XL ultramicrotome and collected at Formvar-coated grids. The ultrathin sections were then treated with buffer A, followed by buffer B and antibodies (anti-NPC1L1 or anti-NPC1) diluted in buffer B. Following rinsing in buffer B the sections were incubated with secondary gold-conjugated antibody diluted in buffer B. Subsequently the sections were rinsed in buffer B, in buffer C, and briefly in water. The sections were finally stained by using 0.4% uranyl acetate in Methocell and examined in a Zeiss EM 900 electron microscope equipped with a Mega View II digital camera. A morphometric analysis of the labeling intensity of NPC1L1 in the brush border membrane and in the apical part of enterocytes from mucosal explants cultured in the presence or absence of cholesterol was performed as follows: From each culture condition the number of gold particles was counted in the brush border membrane (from tight junction to tight junction) in 20 randomly selected enterocytes and in the apical part of the enterocyte (ϳ2 m into the enterocyte). The ratio between the number of gold particles in the brush border membrane and the apical part of the enterocyte was estimated in the two different culture conditions. A Student's t-test was performed using the Microsoft Office Excel 2007 to determine whether the obtained ratios from enterocytes cultured in the presence or absence of cholesterol were statistically significantly different.
Subcellular fractionation of tissue explants. The mucosa of the explants was fractionated into microvillus membranes (Mic) and intracellular and basolateral membranes (Mg 2ϩ ) and according to the divalent cation precipitation method (2) . Procedures were carried out at 4°C unless otherwise stated. The mucosa was homogenized in mannitol buffer (50 mM mannitol, 2 mM Tris, and 10 g/ml aprotinin-leupeptin, pH 7.1) in a Potter-Elvehjem tissue grinder. The homogenate was cleared by centrifugation at 120 g for 5 min. The supernatant was added MgCl 2 to a final concentration of 10 mM and incubated for 10 min before being centrifuged at 1,100 g to pellet intracellular and basolateral membranes (Mg 2ϩ -pellet). To pellet the microvillus membranes (Mic-pellet) the supernatant was centrifuged at 48,000 g for 30 min.
For detergent-resistant membrane (DRM) analysis Mic-pellets were resuspended in 25 mM HEPES and 150 mM NaCl, pH 7.1 (HB) containing 10 g/ml aprotinin-leupeptin and solubilized with ice-cold 1% Triton X-100 at ice before being mixed with 80% sucrose to obtain a final sucrose concentration of 40%. A 35 to 15% sucrose gradient was layered above the extracted pellet according to (4) . The gradient was centrifuged for 20 -22 h at 217,000 g in a Beckman SW40 Ti rotor before fractions of 1 ml were collected by use of a peristaltic pump.
SDS-PAGE. Protein samples were separated in 10% polyacrylamide gels according to Laemmli (27) and electrotransferred to polyvinylidene difluoride membranes. Following transfer, membranes were treated with blocking reagent (0.5% ovalbumin, 0.1% gelatin, 0.2% Teleostan gelatin, and 2% Tween 20 in HB) after which the membranes were incubated with anti-NPC1L1 and anti-alkaline phosphatase diluted 500 and 2,000 times, respectively, in 0.05% Tween 20 in HB (buffer D) overnight. The membranes were briefly rinsed in buffer D before incubation with HRP-conjugated secondary antibody diluted in buffer D. After a rinse in buffer D the membranes were developed with ECL Western blot detection kit according to manufacturer's protocol and examined in the Fujifilm LAS 1000 equipped with the Intelligent Dark Box II.
RESULTS
Cholesterol induces trafficking of NPC1L1 from the brush border to endosomes. By Western blot NPC1L1 was found to migrate as a 150-kDa protein in agreement with the reported size of the human NPC1L1 (12) . By subcellular fractionation it was found to reside mainly in the microvillar membrane and to a smaller extend in the Mg 2ϩ -precipitated membranes containing intracellular and basolateral membranes (Fig. 1) . The observed distribution was similar to that of the intestinal alkaline phosphatase, a glycosylphosphatidylinositol (GPI) anchored brush border membrane protein demonstrating that NPC1L1 mainly resides in the brush border membrane of the porcine enterocytes.
Organ culture of explants in the presence and absence of bile and cholesterol was used in the present work to mimic the in vivo postprandial and interprandial/fasting state, respectively. In the absence of cholesterol NPC1L1 resided mainly in the apical membrane of the jejunal enterocyte, but a small fraction was also found in small punctate intracellular compartments ( Fig. 2A) . The basolateral membrane ( Fig. 2A ) and goblet cells (Fig. 3) were free of labeling, and in general less intense labeling was seen in the crypt region compared with the villus region (not shown). Following culture with cholesterol a substantial amount of the NPC1L1 was found in intracellular compartments but some labeling was still present in the brush border (Fig. 2B) . In contrast to NPC1L1, NPC1 resided in intracellular compartments irrespective of the presence or ab- Fig. 2 . Subcellular localization of NPC1L1 and NPC1. Immunofluorescence microscopy of sections of paraffin-embedded mucosal explants cultured in the absence (Control) or presence (ϩchol) of cholesterol for 1 h. In the control NPC1L1 resided mainly in the brush border (A), but a minor fraction was found in punctate intracellular compartments (arrow in high-magnification inset). In the presence of cholesterol NPC1L1 was mainly seen in intracellular compartments (B). NPC1 resided almost exclusively in the intracellular compartments regardless of the presence or absence of cholesterol (C and D). Bar: 20 m.
sence of cholesterol (Fig. 2, C and D) . This localization is in agreement with its role in egress of cholesterol from the endosomal and lysosomal compartments.
For further characterization of the trafficking of NPC1L1, double immunolabeling of NPC1L1 and APN, a major brush border enzyme, was carried out. Figure 3 shows that, whereas NPC1L1 colocalized with APN in the brush border, in control explants only the latter protein remained at the apical surface in the presence of cholesterol. The localization of other resident brush border proteins was further probed with specific antibodies to sucrase-isomaltase and lactase as well as antibodies recognizing a mixture of the major brush border enzymes. None of these brush border markers were internalized in the presence of cholesterol, indicating that the endocytosis of NPC1L1 is a selective process.
The NPC1L1-positive intracellular compartment was characterized by use of the early endosomal marker EEA1. In explants cultured in the presence of cholesterol, a substantial colocalization between NPC1L1 and EEA1 was seen (Fig. 4B) . However, a minor degree of colocalization was also observed in explants cultured without cholesterol (Fig. 4A) . These findings indicate that NPC1L1 traffics from the brush border to early endosomes following culture in the presence of cholesterol.
The above findings were further substantiated by immunoelectron microscopy. In the absence of cholesterol, labeling of NPC1L1 was mainly seen in the brush border whereas a less dense labeling was observed in intracellular compartments (Fig. 5A) . On the other hand, exposure to cholesterol resulted in reduced labeling of the brush border and increased labeling of the terminal web region just below the microvilli (Fig. 5B) and in endosomallike structures (Fig. 5C) . By morphometric analysis the relative labeling of the brush border in explants cultured with cholesterol was found to be reduced to approximately one-third compared with control explants (Fig. 5D) . Regardless of the presence or absence of cholesterol NPC1 was primarily found in endosomal and lysosomal structures and in mitochondria (not shown).
Together the immunofluorescence and the immunogold labeling show that cholesterol, within a time frame of 0.5-1 h, induces a selective internalization of NPC1L1 to an endosomal compartment.
NBD-cholesterol rapidly enters the cytoplasm. Fluorescent NBD-cholesterol has previously been used to track intestinal cholesterol absorption in vivo (44) . Most NBD-cholesterol was detected in the enterocytes 2 h after oral gavage, with the fluorosterol found in cytoplasmic droplets as well as in the cytoplasm. However, the analog was also found in lipoprotein particles in the lamina propria and detected in the blood already 30 min after oral gavage; after 4 h only a minor fraction was still present in the enterocytes. To address the mechanism of cholesterol absorption mucosal explants were cultured in the presence of NBD-cholesterol. Following 15 min of culture at 37°C the cholesterol analog was readily absorbed into the enterocytes (Fig. 6A ). It localized diffusively over the entire cytoplasm, with the most intense fluorescence seen at the apical side of the nucleus. Preincubation and culture in the presence of chlorpromazine, which is known to inhibit clathrin-mediated endocytosis (49) , caused a similar cytoplasmic distribution of the cholesterol analog (Fig. 6B) , indicating that cholesterol is not taken up by clathrin-mediated endocytosis. Likewise, culture at 4°C, which generally blocks all membrane traffic, also did not prevent uptake of NBD-cholesterol in explants cultured for 1 h at 4°C (Fig. 6C) . Unlike the NBD-cholesterol, the NPC1L1 remained in the brush border following culture at 4°C for 1 h (Fig. 6D) . Together these results thus show that NBD-cholesterol is not taken up by endocytosis but enters the cytoplasm directly after translocation across the brush border membrane. In addition they suggest that NPC1L1 acts as a membrane transporter rather than as an endocytic receptor, since if cholesterol were to be absorbed by an endocytic receptor a labeling pattern of the analog similar to that seen for NPC1L1 cultured in the presence of cholesterol would have been expected.
NPC1L1 is largely excluded from lipid rafts. The cellular plasma membrane is known to be organized into transient cholesterol-and sphingolipid-enriched microdomains, also known as lipid rafts (28) . However, the brush border membrane of the enterocyte contains lipid rafts that are independent of cholesterol and more stable compared with rafts in other cell types (20) . To determine whether NPC1L1 resides in lipid rafts, a DRM analysis by extraction with ice-cold 1% Triton X-100 followed by sucrose density centrifugation was carried out. Figure 7 shows that NPC1L1 was detected in all the gradient fractions; however, most was found in the heavy fractions representing the detergentsoluble fraction and only a smaller part resided in the lighter fractions representing DRMs. Unlike NPC1L1, the GPI-anchored intestinal alkaline phosphatase resides predominantly in the DRM fractions. Since lipid rafts in the enterocyte are considered to be stable, this finding suggests that NPC1L1 might reside in a relative mobile part of the brush border membrane.
DISCUSSION
Although NPC1L1 has previously been shown to localize in the brush border of enterocytes (1, 23, 38) , the cholesterol dependency of the localization of NPC1L1 was not addressed in these studies. In the present study we have shown that in the absence of luminal cholesterol the major part of the NPC1L1 protein resides in the brush border of the enterocyte. However, following culture in the presence of cholesterol, mimicking a meal rich in cholesterol, NPC1L1 selectively relocates to EEA1-positive intracellular compartments. The purpose of this trafficking either could be that NPC1L1 acts as an endocytic cholesterol receptor equivalent to for instance the LDL-receptor (19) or it could be a mechanism to minimize the absorption of cholesterol by downregulating the presence of the transporter in the brush border. In favor of NPC1L1 acting as an endocytic receptor is the fact that, in a hepatoma cell line, it was shown that cholesterol was absorbed by clathrin-mediated endocytosis either by use of RNA interference to silence the expression of clathrin heavy chain (16) or by potassium depletion (5). Furthermore, ezetimibe blocked absorption by impeding endocytosis of cholesterol (16) , leading to the hypothesis that NPC1L1 acts as a recycling cholesterol receptor. In support of NPC1L1 acting as a transporter stands the fact that NPC1 has been shown to act as a transmembrane pump using a proton motive force (9); with a similar membrane topology NPC1L1 can be expected to work by an equivalent mechanism. The observed uptake of NBD-cholesterol into the cytoplasm of enterocytes in explants where endocytosis was inhibited either by low temperature or by chlorpromazine implies that cholesterol is absorbed by a membrane transporter-mediated mechanism rather than by endocytosis. NBD-cholesterol has previously been shown to distribute like cholesterol in the enterocytes (44), although some mistargeting to the mitochondria in Chinese hamster ovary cells has been reported (31) . More specifically, NBD-cholesterol has been shown to bind to sterol carrier protein 2 (SCP2), steroidogenic acute regulatory protein (17) , and NPC1 (29) . Whether NBD-cholesterol is able to interact with NPC1L1 is not known but it must be considered likely due to the homology with NPC1. Although our data do not show directly that NPC1L1 is responsible for the uptake of NBD-cholesterol, it is generally accepted that NPC1L1 is the main player in cholesterol uptake (1, 13, 15, 50) .
Cholesterol is known to be present in the cytoplasm bound to cytosolic carriers for example the SCP2 and the oxysterolbinding protein related proteins (30, 37) . The cytoplasmic localization of the NBD-cholesterol therefore may contribute to a cytoplasmic pool of carrier-bound cholesterol.
In the brush border of the enterocyte the lipid rafts are believed to be large and stable compared with rafts in other cell types and furthermore the rafts has been shown not to be dependent on cholesterol but instead to depend on glycolipids (7) with the galectin-4 (3), galectin-2 (45), and intelectin (51) acting as stabilizers. The finding of NPC1L1 primarily in the detergent-soluble fraction suggests that the major part of the protein resides in the nonraft area of the membrane, which may be a relatively mobile part of the brush border membrane. This segregation may explain why NPC1L1 is selectively endocytosed following culture with cholesterol.
It is well known that the intestine is capable to sense and respond to nutrients present in the lumen by recruiting the proteins involved in the uptake to the brush border from an intracellular storage compartment. Such a rapid recruitment has been observed for the GLUT2 transporter protein involved in absorption of glucose (24) . Another protein involved in the uptake of glucose, SGLT1, has been shown to distribute between the brush border and intracellular compartments with an 1:2 ratio and with the latter proposed to be a reserve pool for the brush border (25) . In this study we have found that NPC1L1 traffics in the opposite direction, in other words from the brush border to endosomes following culture with cholesterol. This suggests that NPC1L1 senses the luminal cholesterol level and is internalized to minimize cholesterol absorption. A similar sensing mechanism has previously been suggested to apply to the heme carrier protein 1, which is found to be localized in the brush border membrane of the enterocyte under iron-depleted conditions but found intracellularly following iron replenishing (39) . From a whole body perspective this sensing mechanism makes sense as excess of both cholesterol and iron are considered to be toxic (18, 35) .
It is a well-established fact that the cholesterol homeostasis is regulated by feedback inhibition of both HMG CoA reductase and the LDL receptor (19) , and the observed trafficking of NPC1L1 might add another level to regulation of the body's cholesterol homeostasis, but clearly more work is needed to fully elucidate the mechanisms of cholesterol uptake.
